Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19
ISTH Academy, Alex Spyropoulos, 303388
What makes a great scientific presentation
ISTH Academy, Chris Ward & Kellie Machlus, 298432
Current Management of Cancer-Related Thrombosis
ISTH Academy, Casey O'Connell & Anna Falanga, 301118
Pulmonary embolism during the COVID‐19 pandemic: decline in diagnostic procedures and incidence at a University Hospital
ISTH Academy, Cihan Ay, 303290
Heparin‐induced Thrombocytopenia with Thrombosis in COVID‐19 Adult Respiratory Distress Syndrome
ISTH Academy, Richard R. Riker, 303289
Venous Thromboembolism in Critically Ill Patients with Covid‐19: Results of a Screening Study for Deep Vein Thrombosis
ISTH Academy, Julie Delaloye, 301153
A Proposal for Staging COVID‐19 Coagulopathy
ISTH Academy, Jecko Thachil, 298945
Thrombosis and Thromboembolism Related to COVID‐19 A clarion call for obtaining solid estimates from large‐scale multicenter data
ISTH Academy, Stefano Barco, 298944
Incidence of venous thromboembolism in hospitalized patients with COVID‐19
ISTH Academy, Saskia Middeldorp, 298823
COVID‐19 Hypothesis: Activated Protein C for Therapy of Virus‐induced Pathologic Thromboinflammation
ISTH Academy, John Griffin, 298813
Hereditary Haemorrhagic Telangiectasia: a disease not to be forgotten during the COVID‐19 pandemic
ISTH Academy, Eleonora Gaetani, 297689
Emergence of Institutional Antithrombotic Protocols for Coronavirus 2019
ISTH Academy, Kevin P. Cohoon, 297671
Fibrinolytic Therapy for Refractory COVID‐19 Acute Respiratory Distress Syndrome: Scientific Rationale and Review
ISTH Academy, Michael B. Yaffe, 297670
DIC in COVID‐19: Implications for Prognosis and Treatment?
ISTH Academy, Rainer Seitz, 297674
Uncertainties on the prognostic value of D‐dimers in COVID‐19 patients
ISTH Academy, Jean-Christophe Gris, 297673
What do monitoring platelet counts in COVID‐19 teach us?
ISTH Academy, Jecko Thachil, 297672
Thrombotic and Hemostatic Issues in Critical Care Units Managing COVID-19 Webinar
ISTH Academy, Dr. Jerrold H. Levy and Dr. Nicole P. Juffermans, 293464
Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID‐19
ISTH Academy, Nicola Mutch, 293467
Type and dose of heparin in COVID‐19
ISTH Academy, Jecko Thachil, 293466
Direct oral anticoagulant plasma levels striking increase in severe COVID‐19 respiratory syndrome patients treated with antiviral agents. The Cremona experience
ISTH Academy, Sophie Testa, 293465
Lupus anticoagulant is frequent in patients with Covid‐19
ISTH Academy, Inès Harzallah, 293462
Laboratory haemostasis monitoring in COVID‐19
ISTH Academy, Jecko Thachil, 293461
Using heparin molecules to manage COVID‐2019
ISTH Academy, Nigel Key, 293460
High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients
ISTH Academy, Jean-Francois Llitjos, 293468
COVID‐19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance
ISTH Academy, Suzanne Cannegieter, 293239
Response to 'Inaccurate conclusions by Tang and colleagues'
ISTH Academy, Ning Tang, 293253
D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19
ISTH Academy, Zhenlu Zhang, 293252
The Contact Activation System as a Potential Therapeutic Target in Patients with COVID‐19
ISTH Academy, Joseph Shatzel, 293228
Inaccurate conclusions by Tang and colleagues
ISTH Academy, Yonatan Y. Greenstein, 293251
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19: A Comment
ISTH Academy, Ernest E. Moore, 293240
Thromboinflammation and the hypercoagulability of COVID‐19
ISTH Academy, Jean Connors, 293227
Potential of Heparin and Nafamostat Combination Therapy for COVID‐19
ISTH Academy, Hidesaku Asakura, 293463
COVID19 and acute coagulopathy in pregnancy
ISTH Academy, Evangelia Vlachodimitropoulou Koumoutsea, 293247
The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome
ISTH Academy, Marco Ranucci, 293246
RE: ISTH interim guidance to recognition and management of coagulopathy in COVID‐19
ISTH Academy, Satoshi Akima, 293245
Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'
ISTH Academy, Ning Tang, 293244
Reply to "Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy"
ISTH Academy, Rubén Coto‐Hernández, 293243
Hypercoagulability of COVID‐19 patients in Intensive Care Unit. A Report of Thromboelastography Findings and other Parameters of Hemostasis
ISTH Academy, Armando Tripodi, 293242
Thrombocytopenia and Its Association with Mortality in Patients with COVID‐19
ISTH Academy, You Shang, 293241
Reply to the comment
ISTH Academy, Ning Tang, 293207
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
ISTH Academy, Deepa Jayakody Arachchillage, 293206
Pulmonary thrombosis in 2019‐nCoV pneumonia?
ISTH Academy, David Lillicrap, 293205
Ask the expert with Jeffrey Weitz - Topic: COVID-19 and Thrombosis
ISTH Academy, Jeffrey I. Weitz, 293188
DOACs and ‘newer’ haemophilia therapies in COVID‐19
ISTH Academy, Jecko Thachil, 293192
Exploring possible mechanisms for COVID‐19 induced thrombocytopenia: Unanswered Questions
ISTH Academy, Maha Othman, 293191
Webinar: Thrombosis, Thromboprophylaxis & Coagulopathy in COVID- 19 Infections
ISTH Academy, Marcel Levi & Beverley Jane Hunt, 291581
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
ISTH Academy, Feng Wang, 293190
Tissue Plasminogen Activator (tPA) Treatment for COVID‐19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series
ISTH Academy, Hunter Moore, 291588
The versatile heparin in COVID‐19
ISTH Academy, Jecko Thachil, 291578
Association between myelofibrosis and thromboembolism: A population‐based retrospective cohort study
ISTH Academy, Walid Saliba, 291528
An anti‐factor IXa/factor X bispecific antibody, emicizumab, improves ex vivo coagulant potentials in plasma from patients with acquired hemophilia A
ISTH Academy, Keiji Nogamimi, 291529
Considerations when choosing an appropriate bleeding risk assessment tool for patients with atrial fibrillation
ISTH Academy, Gaia Giovanna Cavalleri, 291530
Anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura do not hamper ELISA‐based quantification of ADAMTS13 antigen
ISTH Academy, po-hsin Pai, 291531
Structure and function of the ubiquitin‐proteasome system in platelets
ISTH Academy, Andreas Greinacher, 291532
What the neighbors say
ISTH Academy, Faculty / Presenter(s), 291533
Crosstalk between hemostasis and lymphangiogenesis
ISTH Academy, Katsue Suzuki-Inoue, 291534
The factor XIII‐A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations
ISTH Academy, Alisa Wolberg, 291535
Age‐adjusted D‐dimer cutoff for the diagnosis of pulmonary embolism: A cost‐effectiveness analysis
ISTH Academy, Marc Blondon, 291536
Accuracy of HAS‐BLED and other bleeding risk assessment tools in predicting major bleeding events in atrial fibrillation: A network meta‐analysis
ISTH Academy, Yimin Cui, 291537
Fibrinogen αC‐regions are not directly involved in fibrin polymerization as evidenced by a “Double‐Detroit” recombinant fibrinogen mutant and knobs‐mimic peptides
ISTH Academy, Robert Ariëns, 291538
Combined anti‐CD20 and mTOR inhibition with factor VIII for immune tolerance induction in hemophilia A patients with refractory inhibitors
ISTH Academy, Lindsey George, 291539
Contact activation‐induced complex formation between complement factor H and coagulation factor XIIa
ISTH Academy, Yaseelan Palarasah, 291540
Proof of concept of a new scale for the harmonization and the standardization of the ETP‐based APC resistance
ISTH Academy, Yaseelan Palarasah, 291541
A sticky proposition: The endothelial glycocalyx and von Willebrand factor
ISTH Academy, Mark Walters & Abdalla Fayyad, 291542
Successful liver transplant from a hemophilia A donor with no development of hemophilia A in recipient
ISTH Academy, Sanaa Rizk, 291543
Activation of metabolite receptor GPR91 promotes platelet aggregation and transcellular biosynthesis of leukotriene C
ISTH Academy, Jesper Haeggstrom, 291544
Cleavage by MMP‐13 renders VWF unable to bind to collagen but increases its platelet reactivity
ISTH Academy, Richard Farndale, 291545
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
ISTH Academy, Sanaa Rizk, 291546
SMIFH2 inhibition of platelets demonstrates a critical role for formin proteins in platelet cytoskeletal dynamics
ISTH Academy, Steve Thomas, 291547
Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patients
ISTH Academy, Flora Peyvandi, 291548
Treatment of cancer‐associated venous thromboembolism: 12‐month outcomes of the placebo versus rivaroxaban randomization of the SELECT‐D Trial (SELECT‐D: 12m)
ISTH Academy, Andrea Marshall, 291549
Localized endothelial‐based control of platelet aggregation and coagulation under flow: A proof‐of‐principle vessel‐on‐a‐chip study
ISTH Academy, Johan Heemskerk, 291550
Evaluation of functional assays for the diagnosis of heparin induced thrombocytopenia using 5B9, a monoclonal IgG that mimics human antibodies
ISTH Academy, Claire Pouplard, 291551
ISTH News and Updates: Join the ISTH Today – Student Membership is Now Free!
ISTH Academy, Faculty / Presenter(s), 291552
Prevalence of confirmed antiphospholipid syndrome in 18‐50 years unselected patients with first unprovoked venous thromboembolism
ISTH Academy, Andrea Marshall, 291553
Whole blood thrombin generation profiles of patients with cirrhosis explored with a near patient assay
ISTH Academy, Ton Lisman, 291554
Issue Information
ISTH Academy, Faculty / Presenter(s), 291555
Disseminated intravascular coagulation in patients with 2019‐nCoV pneumonia
ISTH Academy, Mark Walters & Abdalla Fayyad, 291556
Long‐term risk of postthrombotic syndrome after symptomatic distal deep vein thrombosis: The CACTUS‐PTS study
ISTH Academy, Jean-Philippe Galanaud, 291557
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
ISTH Academy, Ziyong Sun, 290512
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
ISTH Academy, Jecko Thachil, 290506
Disseminated intravascular coagulation in patients with 2019‐nCoV pneumonia
ISTH Academy, David Lillicrap, 290503
Triple therapy in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention/stenting
ISTH Academy, Eliana Torres, 290491
Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: A case report
ISTH Academy, Lorenzo Alberio, 290492
What’s new in VTE risk and prevention in orthopedic surgery
ISTH Academy, Susan R. Kahn, 290493
Hematocrit and incidence of venous thromboembolism
ISTH Academy, Aaron R. Folsom, 290494
Attention and citation: Common interests of researchers and journals
ISTH Academy, Mary Cushman, 290495
Quantifying single‐platelet biomechanics: An outsider’s guide to biophysical methods and recent advances
ISTH Academy, Raghavendra Palankar, 290496
Hemophilia management: Huge impact of a tiny difference
ISTH Academy, Karin Fijnvandraat, 290497
Increased von Willebrand factor levels in polycythemia vera and phenotypic differences with essential thrombocythemia
ISTH Academy, Maurice Theunissen, 290498
Maternal death and postpartum hemorrhage in sub‐Saharan Africa – A pilot study in metropolitan Mozambique
ISTH Academy, Annette von Drygalski, 290499
ISTH Academy, Faculty / Presenter(s), 290500
Pathways in Thrombosis and Hemostasis
ISTH Academy, Alisa Wolberg & Helen Philippou, 290529
Acquired Glanzmann thrombasthenia associated with platelet desialylation
ISTH Academy, Shiying Silvia Zheng, 290470
Clinical pre‐test probability adjusted versus age‐adjusted D‐dimer interpretation strategy for DVT diagnosis: A diagnostic individual patient data meta‐analysis
ISTH Academy, Sameer Parpia, 290471
Effects of nebulized antithrombin and heparin on inflammatory and coagulation alterations in an acute lung injury model in rats
ISTH Academy, Antonio Artigas, 290472
Issue Information
ISTH Academy, Faculty / Presenter(s), 290486
Defining trauma‐induced coagulopathy with respect to future implications for patient management: Communication from the SSC of the ISTH
ISTH Academy, Paul Kim, 290487
Flow cytometric mepacrine fluorescence can be used for the exclusion of platelet dense granule deficiency
ISTH Academy, Rolf Urbanus, 290488

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings